LITTLE FALLS, N.J., April 1,
2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD)
announced today specific areas of focus and associated actions to
combat the COVID-19 virus. In these unprecedented times, the
company is concentrating on enhanced production, product innovation
and value-add COVID-19 education in support of first-responders and
other healthcare professionals.
"We are doing everything we can to contribute to the global
effort focused on addressing the COVID-19 pandemic," said
George Fotiades, President and Chief
Executive Officer of Cantel. "Supporting those on the front lines,
in addition to our global employee base, is job one, and we are
working closely with distribution partners to ensure that our
masks, PPE and other infection prevention solutions are going to
those who are most in need. Infection prevention is the core of our
company's mission, and we are doing everything possible to deliver
key products and services to serve and protect healthcare
professionals."
Cantel is working across divisions to bring critical products it
manufactures and sells to various end markets to best serve
healthcare providers on the front lines.
Cantel has focused on accelerating surgical earloop mask
production by its HuFriedyGroup dental division, increasing
manufacturing to 24 hours a day, seven days a week at the
organization's two New York
manufacturing sites and expanding manufacturing lines to increase
production volume by over 50%. The enhanced hours and expanded
production capacity have enabled the production of over 4.4 million
masks per week to serve healthcare professionals. Recently, the
organization has increased its manufacturing output on
protective face shields by 50% and anticipates an increase of
output by 100% in two weeks. These products are being deployed to
medical and dental customers.
In addition to masks, HuFriedyGroup is focused on increasing
sourcing through sub-suppliers to increase product availability on
key products lines such as hand sanitizer, hand
sanitizing wipes, protective eye wear, and surface
disinfectants. These products span a variety of HuFriedyGroup
brands including Crosstex, Hu-Friedy, and Palmero.
Cantel is also focused on innovating products that play a major
role on the front lines of combatting COVID-19. On the dental
side, AdvantaClear™ surface disinfectant is
designed to clean and disinfect surfaces while effectively killing
a broad spectrum of disease-causing microorganisms in one minute.
Importantly, AdvantaClear surface disinfectant has been added to
the EPA List N: Disinfectants for Use Against SARS-CoV-2, and is
classified as being effective against SARS-CoV-2, the
cause of COVID-19.
Cantel's ACTRIL™ Cold Sterilant surface
disinfectant, traditionally sold into the life sciences segment, is
another example of unique product innovation. ACTRIL Cold Sterilant
is a powerful disinfectant containing a proprietary mixture of
0.08% peracetic acid and 1.0% hydrogen peroxide. It is effective
against a broad spectrum of organisms, including bacterial
spores, fungal spores, bacteria, mycobacteria, yeast, molds,
and viruses. Cantel is actively working with its medical division
to offer this powerful disinfectant to hospital customers to help
in the fight against infections.
Cantel has made significant investments in the area of
COVID-19 education. The COVID-19 Resource
Center as well as a series of infection prevention
webinars and podcasts, developed by the dental
division, have been visited and attended by close to 20,000 people.
The GreenLight Dental Compliance Center™, a
first-of-its-kind solution, provides a single, convenient online
portal that contains everything a dental practice needs to develop
and maintain a compliant infection prevention program. Cantel
remains focused on providing its customers a "Complete Circle of
Protection" that includes workflow management solutions, instrument
reprocessing, infection prevention, and compliance. The initial
deployment of these programs is to the dental community
through the HuFriedyGroup business. In the weeks and months
ahead, Cantel will look to expand these key educational
resources to the Medivators business serving its medical
customers.
For media inquiries, contact Patrick
Bernardi, HuFriedyGroup Chief Marketing Officer, at
pbernardi@hu-friedy.com or 773.868.5806.
About Cantel Medical:
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, instruments and instrument
reprocessing workflow systems serving the dental industry,
dialysate concentrates, hollow fiber membrane filtration and
separation products. Additionally, we provide technical service for
our products.
For further information, visit the Cantel website
at www.cantelmedical.com.
About HuFriedyGroup:
HuFriedyGroup, a wholly owned
subsidiary of Cantel Medical Corp. (NYSE: CMD), is the global
leader in infection prevention, instrument manufacturing, and
instrument reprocessing workflows, with over 177 years of
collective experience in the dental industry. HuFriedyGroup helps
dental professionals be the best in practice by providing a
complete circle of protection in the dental suite, bringing world
class products, services, education, and communities that result in
superior clinician performance, superior clinical outcomes, and
safety for clinicians and patients. Headquartered in Chicago,
HuFriedyGroup products are distributed in more than 100 countries,
and the company maintains offices in
Germany, Italy, China, Singapore,
and Japan.
For further information, visit www.hu-friedy.com.
About Mar Cor Purification:
Mar Cor Purification,
Inc., a wholly owned subsidiary of Cantel Medical Corp. (NYSE:
CMD), is a water purification company and is the largest supplier
of dialysis medical water systems in North America. It has facilities in 30 cities
in the United States and
Canada, including nine ion
exchange resin regeneration plants strategically located in large
metropolitan areas. Mar Cor also provides turnkey water
purification systems to high purity clients including
pharmaceutical, cosmetics, semiconductor and other bacteria
controlled applications. Unique hollow fiber filtration/separation
products and Peracetic acid (PAA) disinfectants are provided
through a worldwide distribution network.
For further information, visit www.mcpur.com
About Medivators:
Medivators Inc., a wholly owned
subsidiary of Cantel Medical Corp. (NYSE: CMD), is a leader in the
design, development and manufacture of medical devices critical to
endoscopy and infection prevention. The company offers a
comprehensive line of endoscope reprocessing products including
market-leading detergents, disinfectants and sterilants;
technologically advanced automated endoscope reprocessors;
single-use valves and other endoscopy procedure products; drying
and storage cabinets; and equipment tracking systems. Our product
and service offerings come together in our Complete Circle of
Protection, an infection prevention program designed to help
customers streamline reprocessing workflow, improve department
efficiency, and reduce the risk of infection.
For more information visit www.medivators.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-announces-initiatives-to-help-fight-covid-19-301033435.html
SOURCE Cantel Medical Corp.